Concussion Recovery and Support Program
- Conditions
- Brain ConcussionMild Traumatic Brain InjuryHeadache
- Registration Number
- NCT07097792
- Lead Sponsor
- Seattle Children's Hospital
- Brief Summary
Pilot randomized controlled trial (RCT) comparing a novel intervention Concussion Recovery and Support Program (CRISP) for adolescents and young adults (AYA) 18-30 yo with concussion/ mild TBI.
- Detailed Description
We are conducting a pilot study to examine the feasibility, acceptability and pilot efficacy of a novel intervention called CRISP for young adults with persistent concussion/ mTBI. CRISP is an adaptation of an evidence-based treatment for chronic pain called Emotional Awareness and Expression Therapy (EAET). EAET targets underlying emotional responses that appear to drive persistent symptoms, and has been found effective for treating headache and other types of pain in randomized controlled trials with moderately strong effect sizes (0.4-0.5).
Individuals who participate in this study will complete 8 sessions of CRISP with a trained therapist over zoom (each 60 minutes) and will also fill out surveys at multiple time points (baseline, 4 weeks, 8 weeks).
Aim 1: Evaluate feasibility and acceptability of CRISP with a pilot study of n=40 individuals with concussion ages 18-30 years. Hypothesis: CRISP will be a feasible and acceptable approach to treating AYA with concussion.
Aim 2: Collect pilot data regarding efficacy of CRISP for reducing concussion symptoms and improving function. Hypothesis: Pilot data may show benefit from this approach for improving recovery, though we do not expect significance given the sample size.
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 40
- Diagnosed with a concussion and at least 2 weeks from injury but less than one year.
- New or worsening headache since concussion
- Had at least one day with headache last week of moderate severity or two days with headache of any severity
- Non-English speaking
- Acute mental health issues such as active suicidality, psychiatric hospitalization within the past 6 months, ER visit for suicidality in the past 6 months or experiencing psychosis or delusions
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Treatment Evaluation Inventory, short form 8 weeks Self-report form regarding acceptability of treatment approach
- Secondary Outcome Measures
Name Time Method HIT6 (Headache Impact Test, 6 item) Baseline, 4 weeks, 8 weeks (trajectory over time) Self-report measure of headache severity
Chronic Headache Quality of Life Questionnaire (CHQLQ) Baseline/ 4 weeks/ 8 weeks (Trajectory over time) Self-report measure of headache severity with a particular focus on impact on QoL
Fatigue and Altered Cognition Scale (FACS) Baseline/ 4 weeks/ 8 weeks (trajectory over time) 20 item self-report scale measuring issues with fatigue and cognition
Fear of Concussive Symptoms Questionnaire (FOCSQ) Baseline/ 4 weeks/ 8 weeks (trajectory over time) Self-report measure of fear-avoidance of activities due to concussive symptoms
Post Concussion Symptom Scale (PCSS) Baseline/ 4 weeks/ 8 weeks (trajectory over time) Self-report measure of concussive symptoms
Headache severity and frequency (HQ) Baseline/ 4 weeks/ 8 weeks (trajectory over time) 3 item scale to rate frequency, severity and bothersomeness of headaches
PROMIS anxiety Baseline/ 4 weeks/ 8 weeks (trajectory over time) 8 item scale to measure self-report of anxiety
PROMIS depression Baseline/ 4 weeks/ 8 weeks (trajectory over time) 8 item scale to measure self-report of depressive symptoms
Emotional Approach Coping (EAC) Baseline/ 4 weeks/ 8 weeks (trajectory over time) Self-report survey to measure ability to acknowledge and express emotion
Psychological Insight Baseline/ 4 weeks/ 8 weeks (trajectory over time) 6 item self-report scale to measure psychological insight
Pittsburgh Sleep Quality Inventory (PSQI) Baseline/ 4 weeks/ 8 weeks (trajectory over time) Self-report measure of sleep quality
Brief Irritability Test (BITe) Baseline/ 4 weeks/ 8 weeks (trajectory over time) 5 item measure of irritability
Trial Locations
- Locations (2)
Seattle Children's Research Institute
🇺🇸Seattle, Washington, United States
University of Washington
🇺🇸Seattle, Washington, United States
Seattle Children's Research Institute🇺🇸Seattle, Washington, United StatesSara P Chrisman, MD MPHContact206-884-1490crisp@seattlechildrens.org